T2 Biosystems Inc. (NASDAQ: TTOO)
$0.5173
+0.0073 ( -3.18% ) 903.5K
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Market Data
Open
$0.5173
Previous close
$0.5100
Volume
903.5K
Market cap
$10.63M
Day range
$0.4750 - $0.5910
52 week range
$0.4156 - $8.3799
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Nov 20, 2024 |
def | Proxies and info statements | 6 | Nov 20, 2024 |
8-k | 8K-related | 15 | Nov 15, 2024 |
10-q | Quarterly Reports | 82 | Nov 14, 2024 |
pre | Proxies and info statements | 6 | Nov 08, 2024 |
8-k | 8K-related | 13 | Nov 08, 2024 |
8-k | 8K-related | 14 | Oct 16, 2024 |
8-k | 8K-related | 15 | Oct 07, 2024 |
8-k | 8K-related | 15 | Sep 20, 2024 |
4 | Insider transactions | 1 | Sep 17, 2024 |